These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 24355549)
1. Results of repeated transsphenoidal surgery in Cushing's disease. Long-term follow-up. Valderrábano P; Aller J; García-Valdecasas L; García-Uría J; Martín L; Palacios N; Estrada J Endocrinol Nutr; 2014 Apr; 61(4):176-83. PubMed ID: 24355549 [TBL] [Abstract][Full Text] [Related]
2. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease. Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356 [TBL] [Abstract][Full Text] [Related]
3. Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD). Wagenmakers MA; Netea-Maier RT; van Lindert EJ; Timmers HJ; Grotenhuis JA; Hermus AR Clin Endocrinol (Oxf); 2009 Feb; 70(2):274-80. PubMed ID: 18616702 [TBL] [Abstract][Full Text] [Related]
4. Surgical outcomes in patients with Cushing's disease: the Cleveland clinic experience. Johnston PC; Kennedy L; Hamrahian AH; Sandouk Z; Bena J; Hatipoglu B; Weil RJ Pituitary; 2017 Aug; 20(4):430-440. PubMed ID: 28265841 [TBL] [Abstract][Full Text] [Related]
5. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas. Fomekong E; Maiter D; Grandin C; Raftopoulos C Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645 [TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease. Rollin G; Ferreira NP; Czepielewski MA Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1355-61. PubMed ID: 18209874 [TBL] [Abstract][Full Text] [Related]
7. Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing's disease: care reality in the Munich Metropolitan Region. Dimopoulou C; Schopohl J; Rachinger W; Buchfelder M; Honegger J; Reincke M; Stalla GK Eur J Endocrinol; 2014 Feb; 170(2):283-92. PubMed ID: 24217937 [TBL] [Abstract][Full Text] [Related]
8. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Cushing's disease remission after transsphenoidal surgery based on early serum cortisol dynamics. Costenaro F; Rodrigues TC; Rollin GA; Ferreira NP; Czepielewski MA Clin Endocrinol (Oxf); 2014 Mar; 80(3):411-8. PubMed ID: 23895112 [TBL] [Abstract][Full Text] [Related]
10. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease. Amlashi FG; Swearingen B; Faje AT; Nachtigall LB; Miller KK; Klibanski A; Biller BM; Tritos NA J Clin Endocrinol Metab; 2015 Oct; 100(10):3770-7. PubMed ID: 26196950 [TBL] [Abstract][Full Text] [Related]
11. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience. Hameed N; Yedinak CG; Brzana J; Gultekin SH; Coppa ND; Dogan A; Delashaw JB; Fleseriu M Pituitary; 2013 Dec; 16(4):452-8. PubMed ID: 23242860 [TBL] [Abstract][Full Text] [Related]
12. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission. Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716 [TBL] [Abstract][Full Text] [Related]
13. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery. Patil CG; Prevedello DM; Lad SP; Vance ML; Thorner MO; Katznelson L; Laws ER J Clin Endocrinol Metab; 2008 Feb; 93(2):358-62. PubMed ID: 18056770 [TBL] [Abstract][Full Text] [Related]
14. Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging. Prevedello DM; Pouratian N; Sherman J; Jane JA; Vance ML; Lopes MB; Laws ER J Neurosurg; 2008 Oct; 109(4):751-9. PubMed ID: 18826366 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of endoscopic transsphenoidal surgery for Cushing's disease. Brady Z; Garrahy A; Carthy C; O'Reilly MW; Thompson CJ; Sherlock M; Agha A; Javadpour M BMC Endocr Disord; 2021 Mar; 21(1):36. PubMed ID: 33658018 [TBL] [Abstract][Full Text] [Related]
16. Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery. Pouratian N; Prevedello DM; Jagannathan J; Lopes MB; Vance ML; Laws ER J Clin Endocrinol Metab; 2007 Sep; 92(9):3383-8. PubMed ID: 17595252 [TBL] [Abstract][Full Text] [Related]
17. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease. Acebes JJ; Martino J; Masuet C; Montanya E; Soler J Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780 [TBL] [Abstract][Full Text] [Related]
18. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature. Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752 [TBL] [Abstract][Full Text] [Related]